Carbon-based nanomaterials for CRISPR/Cas delivery: a perspective on the design approach

This perspective article delves into the evolving landscape of non-viral vectors for efficient CRISPR delivery, addressing the challenges associated with viral vectors and highlighting the potential of carbon-based nanomaterials as promising alternatives. The article underscores the importance of de...

Full description

Saved in:
Bibliographic Details
Published in:Carbon Letters 2024, 34(1), , pp.387-397
Main Authors: Safarkhani, Moein, Saeb, Mohammad Reza, Lee, Jeong-Hwan, Huh, Yun Suk, Rabiee, Navid
Format: Article
Language:English
Subjects:
Acids
Biomedical materials
Carbon
CRISPR
Cytotoxicity
Design
FDA approval
Gene therapy
Gene transfer
Genetic engineering
Morphology
Nanocomposites
Nanomaterials
Nanoparticles
Nanotechnology
Toxicity
Vectors (Biology)
자연과학일반
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This perspective article delves into the evolving landscape of non-viral vectors for efficient CRISPR delivery, addressing the challenges associated with viral vectors and highlighting the potential of carbon-based nanomaterials as promising alternatives. The article underscores the importance of design strategies in enhancing the interactions between CRISPR components and carbon-based nanomaterials. Various design approaches are explored, including the incorporation of modified nanoparticles between carbonic layers and the creation of unique morphologies to facilitate optimal CRISPR interactions. Specific case studies are presented to exemplify the effectiveness of carbon-based nanomaterials in CRISPR delivery. This perspective sheds light on the dynamic field of non-viral CRISPR delivery vectors, emphasizing the significance of design strategies and showcasing the promising outcomes achieved through the utilization of carbon-based nanomaterials. The provided insights contribute to the ongoing efforts to develop efficient and safe methods for gene delivery and therapy.
ISSN:1976-4251
2233-4998
DOI:10.1007/s42823-023-00655-4